A relevant study demonstrated that when treated with 5AC or DAC, the CDA enzyme activity of male MDS patients was higher than that of female MDS patients; furthermore, these male patients showed worse overall survival [12]. The gene discussed is CDA; the disease is myelodysplastic syndrome.